Sunrise BioResearch
Tirzepatide
Finnrick tested 3 samples of Tirzepatide (GLP-1 and GIP agonist) from Sunrise BioResearch between 16 Jul 2025 and 15 Jan 2026. Test scores average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).
Finnrick Rating™
Tentative Rating
Sunrise BioResearch
Tirzepatide
Tested 3 Samples
Last test 15 Jan 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Tirzepatide tests from top-rated vendors:
All Tirzepatide tests from Sunrise BioResearch
Samples are tested in commercial labs
Tests Count
3
Scores
AVGMINMAX
Last
15 Jan 2026
First
16 Jul 2025
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Batch | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 15 Jan 2026 | View | 30mg | 30.7mg | 33mg | +7.6% | 99.80% | GP2OCT25-01 | Black & White Label / Silver Crimp / Pink Cap | Lab G | Public | |
| 21 Aug 2025 | View | 20mg | (no batch claim) | 20mg | 99.94% | (no batch ID) | Blue Label / Silver Crimp / Gray Cap | Lab E | Public | ||
| 16 Jul 2025 | View | 20mg | (no batch claim) | 20.8mg | +4.0% | 99.87% | (no batch ID) | Blue Label / Silver Crimp / Grey Cap | Lab E | Public | |